Not all saturated fatty acids are the same in relation to type 2 diabetes risk….
Read More »Monthly Archives: August 2014
Improving Outcomes with SGLT-2 Inhibitors in Challenging T2DM Patients, Part 4
In this last of a comprehensive series of four Homerun Slides sets on SGLT-2 inhibitors, we delve deeper into how this drug class can work in challenging patient populations, incuding older and renally-impaired patients. In addition, the beneficial effects on weight and blood pressure are discussed…. To download the complete …
Read More »Improving Outcomes with SGLT-2 Inhibitors in Challenging T2DM Patients, Part 3
In this third set of a series of four Homerun Slides on SGLT-2 inhibitor medications, we cover LX4211, an SGLT-1 and SGLT-2 dual inhibitor, and then explore some of the safety concerns around SGLT-2 inhibitors including the safety of this drug class for older patients. We also review some of …
Read More »Improving Outcomes with SGLT-2 Inhibitors in Challenging T2DM Patients, Part 2
In this second set of a comprehensive four-part series of Homerun Slides on SGLT-2 inhibitors, we review some of the data of the second and third approved SGLT-2 inhibitors in the U.S., dapagliflozin (Farxiga) and empagliflozin (Jardiance), along with the Durability and Limitations of this drug class…. To download this …
Read More »Improving Outcomes with SGLT-2 Inhibitors in Challenging T2DM Patients, Part 1
In this first of a series of four sets of Homerun Slides, we review the basics of SGLT-2 inhibitors incuding Mode of Action, and Efficacy. and then look at how Canagliflozin has worked in poorly controlled type 2 diabetes patients…. To download the complete set in PowerPoint (.ppt) format, just …
Read More »Letter from the Editor #743
I am sure many of you have received an email or Facebook post to participate in the ALS Ice Bucket Challenge. I am amazed by the number of people who will actually have a bucket of ice poured over their heads, yet will not take the time to check their …
Read More »Editor’s Note, DCMS #202
MODY, cystic fibrosis, and Wolfram syndrome all have something in common. Believe it or not, they are all a form of diabetes. This week, our Clinical Text from the Handbook of Diabetes looks at these and other types or non-traditional causes of diabetes. Our Homerun Slides focus on how to …
Read More »IDF Diabetes Atlas – Middle East and North Africa
Diabetes is a huge and growing problem, and the costs to society are high and escalating. In the Middle East and North Africa, 1 in 10 adults has diabetes. The Top 5 countries for prevalence in this region are: Saudi Arabia, Kuwait, Qatar, bahrain, and the united Arab Emirates. To …
Read More »Stanley Schwartz, MD: Classifying Diabetes Types, ADA 2014, Part 3
In this week’s Homerun Slides, Dr. Stanley Schwartz continues his exploration of a beta-cell centric classification model for diabetes and includes a detailed diagram explanation featuring the Egregious Eleven….
Read More »Handbook of Diabetes, 4th Edition, Excerpt #7: Other Types of Diabetes
Rudy Bilous, MD, FRCP Richard Donnelly, MD, PHD, FRCP, FRACP Maturity-onset diabetes of the young Maturity-onset diabetes of the young (MODY) owes its name to a time when diabetes was defined by age of onset. The nomenclature has stuck, however, and MODY defines usually non-insulin dependent diabetes occurring before the age …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.